Purple Biotech CEO Gil Efron takes medical leave, Isaac Israel named acting CEO

Mar. 24, 2023 7:18 AM ETPurple Biotech Ltd. (PPBT), KITVFBy: Meghavi Singh, SA News Editor
  • Purple Biotech (NASDAQ:PPBT) on Friday said that the CEO, Gil Efron, has been hospitalized following a mishap and will be on medical leave, which is expected to last several months while he undergoes rehabilitation to recover from his injuries.
  • The board appoints Isaac Israel, a current board member and the former CEO, to serve as acting CEO during Gil Efron’s absence.
  • The company’s business plan and clinical development programs continue as planned.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.